​

Funding Round

Series C - Sunesis Pharmaceuticals

Series C - Sunesis Pharmaceuticals

Investment Firm

Overview

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

Announced Date

Sep 16, 2004

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorCredit Suisse First Boston
Participant InvestorWarburg Pincus
Participant InvestorAbingworth
Participant InvestorBiogen
Participant InvestorMayfield Fund

Round Details and Background

Sunesis Pharmaceuticals raised $14000000 on 2004-09-16 in Series C

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 01, 2015
Post-IPO Equity - Sunesis Pharmaceuticals
-25.0M
Oct 19, 2016
Post-IPO Equity - Sunesis Pharmaceuticals
-25.0M
Apr 01, 2016
Post-IPO Debt - Sunesis Pharmaceuticals
1-15.0M
Apr 07, 2009
Post-IPO Equity - Sunesis Pharmaceuticals
9-43.5M

Recent Activity

There is no recent news or activity for this profile.